F-star Therapeutics Reaches Analyst Target Price
March 08, 2023 at 07:49 AM EST
In recent trading, shares of F-star Therapeutics Inc (FSTX) have crossed above the average analyst 12-month target price of $7.00, changing hands for $7.12/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..